Follow
Fabian Hulpia
Fabian Hulpia
Janssen Pharmaceutica
Verified email at its.jnj.com
Title
Cited by
Cited by
Year
Report on a novel emerging class of highly potent benzimidazole NPS opioids: chemical and in vitro functional characterization of isotonitazene
P Blanckaert, A Cannaert, K Van Uytfanghe, F Hulpia, E Deconinck, ...
Drug Testing and Analysis 12 (4), 422-430, 2020
722020
Combining tubercidin and cordycepin scaffolds results in highly active candidates to treat late-stage sleeping sickness
F Hulpia, D Mabille, GD Campagnaro, G Schumann, L Maes, I Roditi, ...
Nature communications 10 (1), 5564, 2019
592019
Revisiting tubercidin against kinetoplastid parasites: Aromatic substitutions at position 7 improve activity and reduce toxicity
F Hulpia, GD Campagnaro, M Scortichini, K Van Hecke, L Maes, ...
European Journal of Medicinal Chemistry 164, 689-705, 2019
462019
Discovery of Novel 7-Aryl 7-Deazapurine 3′-Deoxy-ribofuranosyl Nucleosides with Potent Activity against Trypanosoma cruzi
F Hulpia, K Van Hecke, C França da Silva, D da Gama Jaen Batista, ...
Journal of Medicinal Chemistry 61 (20), 9287-9300, 2018
402018
First report on brorphine: the next opioid on the deadly new psychoactive substance horizon?
N Verougstraete, MM Vandeputte, C Lyphout, A Cannaert, F Hulpia, ...
Journal of Analytical Toxicology 44 (9), 937-946, 2020
382020
C6–O-alkylated 7-deazainosine nucleoside analogues: Discovery of potent and selective anti-sleeping sickness agents
F Hulpia, J Bouton, GD Campagnaro, IA Alfayez, D Mabille, L Maes, ...
European Journal of Medicinal Chemistry 188, 112018, 2020
352020
Structure Guided Lead Generation toward Nonchiral M. tuberculosis Thymidylate Kinase Inhibitors
L Song, R Merceron, B Gracia, AL Quintana, MDP Risseeuw, F Hulpia, ...
Journal of Medicinal Chemistry 61 (7), 2753-2775, 2018
302018
Discovery of Pyrrolo[2,3-b]pyridine (1,7-Dideazapurine) Nucleoside Analogues as Anti-Trypanosoma cruzi Agents
C Lin, F Hulpia, CF da Silva, DGJ Batista, K Van Hecke, L Maes, G Caljon, ...
Journal of Medicinal Chemistry 62 (19), 8847-8865, 2019
272019
Structure–Activity Relationship Exploration of 3′-Deoxy-7-deazapurine Nucleoside Analogues as Anti-Trypanosoma brucei Agents
F Hulpia, GD Campagnaro, KJ Alzahrani, IA Alfayez, MA Ungogo, ...
ACS Infectious Diseases 6 (8), 2045-2056, 2020
242020
Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter Trypanosoma brucei
AH Alghamdi, JC Munday, GD Campagnaro, D Gurvic, F Svensson, ...
Elife 9, e56416, 2020
212020
New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma
J Verhoeven, F Hulpia, K Kersemans, J Bolcaen, S De Lombaerde, ...
Scientific Reports 9 (1), 2878, 2019
212019
Synthesis and evaluation of 3′-fluorinated 7-deazapurine nucleosides as antikinetoplastid agents
J Bouton, AF d’Almeida, L Maes, G Caljon, S Van Calenbergh, F Hulpia
European Journal of Medicinal Chemistry 216, 113290, 2021
202021
Synthesis of a 3′-C-ethynyl-β-d-ribofuranose purine nucleoside library: discovery of C7-deazapurine analogs as potent antiproliferative nucleosides
F Hulpia, S Noppen, D Schols, G Andrei, R Snoeck, S Liekens, ...
European Journal of Medicinal Chemistry 157, 248-267, 2018
202018
Phenethyl-4-ANPP: a marginally active byproduct suggesting a switch in illicit fentanyl synthesis routes
MM Vandeputte, AJ Krotulski, F Hulpia, S Van Calenbergh, CP Stove
Journal of Analytical Toxicology 46 (4), 350-357, 2022
172022
Synthesis, in vitro and in vivo small-animal SPECT evaluation of novel technetium labeled bile acid analogues to study (altered) hepatic transporter function
S Neyt, M Vliegen, B Verreet, S De Lombaerde, K Braeckman, C Vanhove, ...
Nuclear Medicine and Biology 43 (10), 642-649, 2016
162016
Deazapurine nucleoside analogues for the treatment of Trichomonas vaginalis
MJ Natto, F Hulpia, ER Kalkman, S Baillie, A Alhejely, Y Miyamoto, ...
ACS Infectious Diseases, 2021
122021
Report on a New Opioid NPS: Chemical and In Vitro Functional Characterization of a Structural Isomer of the MT-45 Derivative Diphenpipenol
A Cannaert, F Hulpia, M Risseeuw, K Van Uytfanghe, E Deconinck, ...
Journal of Analytical Toxicology 45 (2), 134-140, 2021
122021
N6-modification of 7-deazapurine nucleoside analogues as anti-Trypanosoma cruzi and anti-Leishmania agents: Structure-activity relationship exploration and in vivo evaluation
C Lin, DGJ Batista, AL Mazzeti, RD Girao, GM de Oliveira, I Karalic, ...
European Journal of Medicinal Chemistry 231, 114165, 2022
112022
2-((3,5-Dinitrobenzyl)thio)quinazolinones: Potent Antimycobacterial Agents Activated by Deazaflavin (F420)-Dependent Nitroreductase (Ddn)
Y Jian, HE Forbes, F Hulpia, MDP Risseeuw, G Caljon, ...
Journal of medicinal chemistry 64 (1), 440-457, 2020
112020
Endeavors towards transformation of M. tuberculosis thymidylate kinase (MtbTMPK) inhibitors into potential antimycobacterial agents
Y Jian, R Merceron, S De Munck, HE Forbes, F Hulpia, MDP Risseeuw, ...
European Journal of Medicinal Chemistry 206, 112659, 2020
112020
The system can't perform the operation now. Try again later.
Articles 1–20